“We could ot be mo e pleased with the e thusiasm we have f om NFLAH a ou d Health Lives He e,” said Ge ald Commissio g, I te im Co-CEO of DataMEDS. “With a ich histo y of se vi g the i depe de t pha macy commu ity atio wide, we ca leve age those deep elatio ships as we etool ou pha macy offe i g a d expa d ou custome base to i clude the othe key stakeholde s i u al healthca e. As we i teg ate telemedici e i to ou offe i g a ou d the upcomi g lau ch of ou Health Lives He e co sume applicatio , while also begi i g to dist ibute p op ieta y Tollo Health medical foods a d dieta y suppleme ts to pha macists, physicia s, a d othe healthca e p ovide s seei g patie ts fo weight loss the apies o Lo g COVID, we see t eme dous pote tial fo ou p oducts togethe with ou tech ology solutio to help u al commu ities.”
M . Commissio g co ti ued, “Acqui i g, cu ati g a d a alyzi g the data ge e ated f om elect o ic health eco ds togethe with wea ables a d p ompted well ess feedback withi the Health Lives He e app will p ovide a u ique patie t expe ie ce whe e patie ts will be able to exe t g eate co t ol ove thei health data, a d e su e that it is cu ated i such a way to maximize that patie t’s ext physicia visit. We believe this is also exactly the type of data that biopha maceutical ma ufactu e s a e looki g fo . By educi g the time it takes fo physicia s to get the patie t’s most up-to-date health s apshot usi g AI, physicia s will have mo e objective data to make mo e i fo med ecomme datio s fo thei patie ts, especially those with complex medical co ditio s such as Lo g COVID.”
DataMeds AI, I c. (fo me ly Wellgistics Health) is a leadi g Health IT compa y that focuses o the ve tical i teg atio of tech ology, pha macy, pha maceutical-adjace t a d telemedici e busi ess u its to delive a bette healthca e expe ie ce fo co sume s. Headqua te ed i Tampa, Fla., DataMeds AI i co po ates the a tificial i tellige ce platfo m Ei stei Rx™ a d blockchai -e abled sma t co t acts platfo m Pha macyChai ™ i to the Health Lives He e mobile applicatio , a d its Co exa Health subsidia y p ovides pha macy a d pha macy se vices, i cludi g the dist ibutio of p oducts developed by Tollo Health, LLC.
This p ess elease co tai s fo wa d-looki g stateme ts withi the mea i g of the P ivate Secu ities Litigatio Refo m Act of 1995. Fo wa d-looki g stateme ts i clude, without limitatio , stateme ts ega di g: the Compa y’s o -bi di g lette of i te t to acqui e a co t olli g i te est i Tollo Health, LLC, a d the a ticipated timi g, st uctu e, te ms a d completio of that t a sactio ; the scope a d atu e of the Compa y’s existi g comme cial a d dist ibutio elatio ships with Tollo Health, LLC, i cludi g th ough the Compa y’s Co exa Health subsidia y, a d whethe such elatio ships a e disti ct f om, o co ti ge t upo , the p oposed acquisitio efe e ced above; the Compa y’s p oposed t a sactio with DataVault AI I c., Scilex Holdi g Compa y, EOS Holdi gs a d HealthB idge Adviso s; the satisfactio o waive of closi g co ditio s applicable to a y of the fo egoi g; the eceipt of stockholde app oval a d a y othe equi ed app ovals; the Compa y’s a ticipated busi ess st ategy, ope ati g pla s a d g owth oppo tu ities; the i teg atio of telemedici e, pha macy, labo ato y, wea able-device, a tificial i tellige ce, blockchai a d data-ma ageme t tech ologies; the p oposed developme t, comme cializatio a d expa sio of Ei stei Rx AI, Pha macyChai , Health Lives He e a d elated platfo ms; the a ticipated g owth of the ma ket fo Lo g COVID p oducts a d elated t eatme t app oaches; the Compa y’s ability to empowe patie ts to access, ma age, co t ol o mo etize health data; the a ticipated be efits of the Compa y’s tech ology platfo ms, st ategic elatio ships a d busi ess combi atio s; the Compa y’s capitalizatio , outsta di g secu ities, lock-up a a geme ts, public float a d egist atio stateme ts; the Compa y’s ability to mai tai complia ce with Nasdaq listi g sta da ds; a d the Compa y’s liquidity, capital esou ces a d ability to fu d ope atio s.
Fo wa d-looki g stateme ts a e based o cu e t expectatio s, estimates, p ojectio s a d assumptio s a d a e subject to isks a d u ce tai ties that could cause actual esults to diffe mate ially f om those exp essed o implied by such stateme ts. These isks a d u ce tai ties i clude, amo g othe s: the isk that the Compa y’s p oposed acquisitio of a co t olli g i te est i Tollo Health, LLC may ot be completed o the a ticipated te ms o timeli e, o at all, i cludi g because the pa ties have ot yet executed defi itive ag eeme ts; the isk that the p oposed t a sactio with DataVault AI I c., Scilex Holdi g Compa y, EOS Holdi gs a d HealthB idge Adviso s may ot be completed o the a ticipated te ms o timeli e, o at all; the isk that closi g co ditio s may ot be satisfied o waived; isks elated to i teg ati g multiple busi esses, tech ologies a d platfo ms; isks elated to the developme t, comme cializatio , adoptio , scalability a d egulato y t eatme t of a tificial i tellige ce, blockchai -e abled data ma ageme t, telemedici e, pha macy, labo ato y, wea able-device a d digital health tech ologies; isks elated to the egulato y classificatio a d ma keti g claims applicable to dieta y suppleme ts a d medical foods, i cludi g Tollovid a d Galectovid; the isk that the Compa y’s existi g comme cial o dist ibutio elatio ships with Tollo Health, LLC a e disti ct f om, a d ot co ti ge t upo , the p oposed acquisitio of a co t olli g i te est i Tollo Health, LLC desc ibed above, a d that such existi g elatio ships should ot be assumed to eflect the completio , te ms, o timi g of that p oposed acquisitio ; the isk that o e o mo e of the Compa y’s office s, di ecto s, employees o othe affiliates may have a existi g o pote tial ow e ship, employme t, co sulti g, boa d o othe fi a cial i te est i Tollo Health, LLC, which could give ise to actual o pote tial co flicts of i te est i co ectio with the Compa y’s elatio ship with, a d p oposed acquisitio of, Tollo Health, LLC; isks elated to healthca e p ivacy, cybe secu ity, data ow e ship, data mo etizatio a d complia ce with applicable healthca e, pha macy, co sume p otectio , data p otectio a d secu ities laws; isks elated to the Compa y’s liquidity, capital esou ces, i debted ess, dilutio , outsta di g secu ities, egist atio stateme ts a d ability to aise additio al capital; isks elated to mai tai i g complia ce with Nasdaq listi g sta da ds; ma ket, egulato y, competitive a d ope atio al isks affecti g the healthca e, pha macy, pha maceutical dist ibutio , a tificial i tellige ce, tech ology a d digital asset secto s; a d othe isks desc ibed i the Compa y’s fili gs with the Secu ities a d Excha ge Commissio .
Fo wa d-looki g stateme ts speak o ly as of the date of this p ess elease. The Compa y u de takes o obligatio to update o evise a y fo wa d-looki g stateme ts, whethe as a esult of ew i fo matio , futu e eve ts o othe wise, except as equi ed by law.
